Target
Beta-lactamase
Ligand
BDBM466991
Substrate
n/a
Meas. Tech.
Inhibition of Beta-Lactamase Enzymes
IC50
420±n/a nM
Citation
 Comita-Prevoir, JDurand-Reville, TFGauthier, LO''Donnell, JRomero, JTommasi, RVerheijen, JCWu, FWu, XZhang, J Beta-lactamase inhibitor compounds US Patent  US10800778 Publication Date 10/13/2020 
Target
Name:
Beta-lactamase
Synonyms:
Beta-lactamase | OXA-48 | Synonyms=blaOXA-48 | bla
Type:
PROTEIN
Mol. Mass.:
30363.94
Organism:
Klebsiella pneumoniae
Description:
ChEMBL_103606
Residue:
265
Sequence:
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
  
Inhibitor
Name:
BDBM466991
Synonyms:
(2S)-2-fluoro-2-[[(2S,5R)-3-methyl-7-oxo-2-[2-(sulfamoylamino)ethyl-carbamoyl]-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy]acetic acid lithium salt | US10800778, Example 75
Type:
Small organic molecule
Emp. Form.:
C12H18FN5O7S
Mol. Mass.:
395.364
SMILES:
CC1=C[C@@H]2CN([C@@H]1C(=O)NCCNS(N)(=O)=O)C(=O)N2O[C@@H](F)C(O)=O |r,t:1|
Structure:
Search PDB for entries with ligand similarity: